IART
Integra LifeSciences Holdings
NASDAQ: IART · HEALTHCARE · MEDICAL DEVICES
$15.50
-0.26% today
Updated 2026-09-11
Market cap
$1.21B
P/E ratio
—
P/S ratio
0.73x
EPS (TTM)
$-0.09
Dividend yield
—
52W range
$9 – $20
Volume
0.8M
Integra LifeSciences Holdings (IART) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.50
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$79.01
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.6B | $1.5B | $1.6B | $1.6B | $1.7B | $1.8B | $1.8B | $1.9B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 3.57% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -0.44%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.